Skip to main contentSkip to navigation
Sirius Investors
Edgewise Therapeutics, Inc.

Edgewise Therapeutics, Inc.

EWTX
NASDAQHealthcare

EWTX Financial Statements & Analysis

Complete financial statements for EWTX including income statement, balance sheet, and cash flow statement. Analyze EWTX's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.

TTM figures are calculated by rolling up the last four quarterly filings (income and cash flow summed; balance sheet at period end).

Income Statement Comparison

Revenue & Net Income

Period Comparison

MetricTTM Q4 '25TTM Q1 '26ChangeImpact
Revenue000.0%
Gross Profit0-590.00K0.0%
Operating Income-191.41M-199.56M4.3%
Net Income-167.79M-176.01M4.9%
EPS-0.41-0.421.9%
EBITDA-167.79M-175.97M4.9%
Gross Margin0.00%0.00%0.0%
Operating Margin0.00%0.00%0.0%
Net Income Margin0.00%0.00%0.0%
R&D Expenses151.39M157.28M3.9%

Income Statement Full Table

Free users can view the last 3 periods. Upgrade to see the full history.

Upgrade
MetricTTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Revenue000
Gross Profit-590.00K00
Operating Income-199.56M-191.41M-180.97M
Net Income-176.01M-167.79M-157.24M
EPS-0.42-0.41-0.40
EBITDA-175.97M-167.79M-154.97M
Gross Margin0.00%0.00%0.00%
Operating Margin0.00%0.00%0.00%
Net Income Margin0.00%0.00%0.00%
R&D Expenses157.28M151.39M144.16M

Our detailed financial analysis helps investors understand EWTX's business performance, operational efficiency, and financial health through comprehensive financial statement data presented in both quarterly and annual formats.

Track EWTX's financial performance metrics including revenue, gross profit, operating income, net income, total assets, liabilities, shareholders' equity, operating cash flow, and free cash flow with historical comparison and trend analysis.

Financial Metrics

Want to dive deeper into EWTX's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.

View Financial Metrics